United States · FDA National Drug Code directory
Aphexda
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82737-073_241b0b4f-eca3-be93-e063-6394a90a5789
- Product NDC
- 82737-073
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Motixafortide
- Labeler
- BioLineRx USA Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230908
- Source listing expiry
- 20261231
Source-listed ingredients
- MOTIXAFORTIDE ACETATE — 62 mg/1.7mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (82737-073-01) / 1.7 mL in 1 VIAL, GLASS · 82737-073-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →